PDCD1 and colorectal carcinoma: Since a better understanding of this phenomenon and the mechanisms involved will have significant preventive and therapeutic implications for CRC, including anti-PD-1 immune checkpoint inhibitor therapy, further investigation is needed including testing of MSI status for such cases.